The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS

University of Indonesia (UI)

Status: Not yet enrolling

Conditions: Irritable Bowel Syndrome

Treatments: Drug: Saccharomyces Boulardii 250 MG; Drug: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT05451433

22-03-0280

Details and patient eligibility

About

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome

Full description

This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome within timeframe of study 28 days and then will be examined the outcome as the improvement quality of life

Enrollment: 52 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criterias:

• 18 years or older
• diagnosed with IBS based on ROME IV criteria
• agree to be participant by signing inform consent

Exclusion Criteria:

• patient who does not want to sign the inform consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

52 participants in 2 patient groups, including a placebo group

Intervention Group

Experimental group

Description:

Get intervention drug Normagut capsule twice a day

Treatment:

Drug: Saccharomyces Boulardii 250 MG

Control Group

Placebo Comparator group

Description:

Get placebo capsule twice a day

Treatment:

Drug: Placebo